Limba
Romanian
Romanian
English|
SR-4835 is a highly selective dual inhibitor of CDK12and CDK13with IC50 of 99 nM and Kd of 98 nM for CDK12 and IC50 of 4.9 nM for CDK13. SR-4835 disables triple-negative breast cancer (TNBC) cells. SR-4835 promotes synergy with DNA-damaging chemotherapy and PARP inhibitors.
| Price | 2.681,00 RON (preturile sunt fara TVA) |
|---|---|
| Description |
SR-4835 is a highly selective dual inhibitor of CDK12and CDK13with IC50 of 99 nM and Kd of 98 nM for CDK12 and IC50 of 4.9 nM for CDK13. SR-4835 disables triple-negative breast cancer (TNBC) cells. SR-4835 promotes synergy with DNA-damaging chemotherapy and PARP inhibitors. |
